Clinical phenotypes associated with type II collagen mutations

Area of Science:

• Genetics
• Orthopedics
• Molecular Biology

Background:

• Mutations in the COL2A1 gene lead to a spectrum of skeletal and cartilage disorders, varying from lethal conditions to milder phenotypes.
• Recognized features include short stature, eye, palate, and hearing abnormalities, but presentation variability is often underestimated.
• COL2A1 mutations can present solely as joint disease, without other typical phenotypic indicators.

Purpose of the Study:

• To investigate the hypothesis that COL2A1 mutations cause novel phenotypes, including premature arthritis and severe bone dysplasias.
• To highlight the diagnostic significance of identifying COL2A1 mutations for risk assessment and natural history understanding.
• To emphasize the importance of early identification for preventative strategies and management of related musculoskeletal conditions.

Main Methods:

• Review of clinical data and genetic testing results for individuals with suspected COL2A1-related disorders.
• Phenotypic analysis correlating specific COL2A1 mutations with clinical presentations.
• Literature review to consolidate understanding of the phenotypic spectrum.

Main Results:

• Confirmed significant variability in COL2A1 mutation phenotypes, including presentations not typically associated with type II collagen disorders.
• Identified cases where COL2A1 mutations manifested primarily as early-onset joint disease.
• Demonstrated a spectrum from mild chondrodysplasias to severe bone dysplasias linked to COL2A1 mutations.

Conclusions:

• COL2A1 mutations are associated with a broader range of skeletal and joint diseases than previously recognized.
• Accurate identification of COL2A1 mutations is crucial for precise diagnosis, recurrence risk assessment, and tailored patient management.
• Early intervention strategies informed by genetic diagnosis can improve outcomes and potentially reduce healthcare costs for musculoskeletal conditions.